Distal Radial Access for Primary PCI in STEMI Patients to Prevent RAO

NCT ID: NCT05461781

Last Updated: 2025-03-11

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

NA

Total Enrollment

512 participants

Study Classification

INTERVENTIONAL

Study Start Date

2022-01-05

Study Completion Date

2023-08-30

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Randomized-controlled trial to compare early radial artery occlusion via distal vs. conventional transradial access among ST segment elevation myocardial infarction patients for primary percutaneous coronary intervention.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conventional transradial access (TRA) is recommended as the default approach for patients undergoing percutaneous coronary intervention (PCI) according to 2018 ESC guidelines. However, radial artery occlusion (RAO) remains the frequent complication, precluding the future use of the radial artery as an access point for repeat coronary recanalization or as a conduit for coronary artery bypass surgery. More than 50% of patients with ST segment elevation myocardial infarction (STEMI) present multiple vascular lesions, of which 50% require reprocessing non-culprit vessels. Therefore, the patency of the radial artery is crucial for STEMI patients. The distal radial access (DRA), located in the anatomical snuffbox or the dorsum of the hand, was introduced as a promising alternative. Three recent RCTs have shown significant reductions of RAO after DRA compared with TRA. Nevertheless, all of them excluded the patients presenting with STEMI. Therefore, we conduct a prospective, single-center, open-label randomized clinical trial to assess the superiority of preventing RAO at 24 h via DRA when compared TRA among STEMI patients for primary PCI.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

ST Segment Elevation Myocardial Infarction

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Single-center, open-label, parallel randomized controlled trial
Primary Study Purpose

PREVENTION

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

distal radial access

Distal radial access for primary percutaneous coronary intervention in STEMI patients

Group Type EXPERIMENTAL

distal radial access

Intervention Type PROCEDURE

primary percutaneous coronary intervention via distal radial access

conventional transradial access

conventional transradial access for primary percutaneous coronary intervention in STEMI patients

Group Type ACTIVE_COMPARATOR

conventional transradial access

Intervention Type PROCEDURE

primary percutaneous coronary intervention via conventional transradial access

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

distal radial access

primary percutaneous coronary intervention via distal radial access

Intervention Type PROCEDURE

conventional transradial access

primary percutaneous coronary intervention via conventional transradial access

Intervention Type PROCEDURE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Age ≥ 18 years
* ST-segment elevation myocardial infarction for primary percuteous coronary intervention
* Palpable pulses on both access sites of the radial artery
* Informed consent

Exclusion Criteria

* Thrombolysis before primary percutaneous coronary intervention
* Previous CABG or radio-cephalic fistula using radial artery
* Cardiogenic shock
* Severe arrhythmias
* Severe liver and kidney dysfunction
* Pregnancy
* Enrolment in another study within 1 month
* Inability to obtain written informed consent
Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Beijing Luhe Hospital

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Jincheng Guo

Role: STUDY_CHAIR

Beijing Luhe Hospital

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Beijing Luhe hospital

Beijing, Beijing Municipality, China

Site Status

Countries

Review the countries where the study has at least one active or historical site.

China

References

Explore related publications, articles, or registry entries linked to this study.

Li Z, Wang Y, Song J, Wang S, Wang Y, Wu Y, Wang H, Liu Z, Yan R, Zhai G, Guo J. Distal radial access to prevent radial artery occlusion for STEMI patients (RAPID III): a randomized controlled trial. BMC Med. 2025 Mar 24;23(1):173. doi: 10.1186/s12916-025-04005-1.

Reference Type DERIVED
PMID: 40128873 (View on PubMed)

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

Beijing LH

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.